Epigenetic Aging Clocks: Can They Reliably Measure

What Are Epigenetic Aging Biomarkers?

DNA methylation is a chemical modification that helps regulate gene activity without changing the underlying DNA sequence. Because methylation patterns shift with age, researchers have developed algorithms—often called epigenetic clocks—that combine measurements from many sites across the genome into an estimated biological-age score.

Different clocks were created for different purposes. Some were trained to predict chronological age, while later models incorporate mortality, disease-related measurements or changes observed across the life course. Their outputs therefore cannot be treated as interchangeable, and a person may receive different biological-age estimates from the same blood sample depending on the algorithm used.

Can Aging Clocks Show Whether a Longevity Intervention Works?

The Nature Medicine analysis focuses on whether epigenetic biomarkers respond consistently to human longevity interventions. This is an important test: a useful trial biomarker should change when an intervention affects the biological process it is intended to target, while remaining reliable enough to distinguish a genuine effect from normal measurement variation.

Responsiveness alone is insufficient, however. A lower epigenetic-age estimate must eventually be shown to predict outcomes that matter to patients, such as reduced disability, fewer cardiovascular events or longer survival. Until that relationship is validated, researchers should interpret clock changes alongside established clinical measurements rather than describing them as proof of rejuvenation.

What Has the CALERIE Trial Taught Researchers About Biological Aging?

The CALERIE phase 2 trial randomly assigned 220 healthy, non-obese adults to a calorie-restriction intervention or an unrestricted control group for two years. The intervention targeted a 25% reduction in calorie intake, although participants achieved a smaller average reduction in practice. It remains one of the most carefully controlled human studies used to investigate whether sustained dietary change can influence processes associated with aging.

A 2023 analysis in Nature Aging evaluated several DNA-methylation measures using stored CALERIE blood samples. The results differed by biomarker: a measure designed to track the pace of aging detected a modest slowing, while several clocks expressed as estimated biological age did not show clear intervention effects. This illustrates why longevity claims should not depend on a single clock and why replication with clinical follow-up remains essential.